1. In Vivo

Device/Diagnostics Quarterly Deal Statistics, Q4 2012

A look at financing, M&A, and alliance activity, October – December 2012

Device firms closed the final quarter of 2012 with $1.1 billion in financing, led by Volcano’s debt offering. Takeovers of Gambro and PSS Medical topped the device M&A list. At $196 million, Q4 diagnostic financing was the lowest quarter of the year, but IPOs returned with three public debuts. Amgen’s $415 million acquisition of deCODE was the largest diagnostic M&A.

Device companies finished off 2012 raising $1.1 billion in the fourth quarter (a 40% increase over Q3’s $801 million), capping off the year with a grand total of $4 billion in funding, falling just a hair short of the $4.1 billion that was amassed in 2011. Similar to last year, there was a strong showing from debt and late-stage venture capital financings across all four quarters. (See Exhibit 1.)

Click here

More from Deal-Making

More from In Vivo